Market Value499,884,000
Total Holdings53
File Date2022-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ODT / Odonate Therapeutics Inc
LPTX / Leap Therapeutics, Inc.
CTMX / CytomX Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
NKTR / Nektar Therapeutics
GNFT / Genfit S.A. - Depositary Receipt (Common Stock)
TCRR / Tcr2 Therapeutics Inc
US83085C1154 / Sky Harbour Group Corp.
RDUS / Radius Recycling, Inc.
/ INSPIRATO INC WARRANT EXP 12/15/2027 0.00000000
US45791E1073 / INSPIRATO INC
DCFC / Tritium DCFC Limited
FBIO / Fortress Biotech, Inc.
FIXX / Homology Medicines, Inc.
SRRA / Sierra Oncology Inc
IONS / Ionis Pharmaceuticals, Inc.
ALEC / Alector, Inc.
RCUS / Arcus Biosciences, Inc.
CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock)
BLU / Bellus Health Inc
TSVT / 2seventy bio, Inc.
BRCC.WS / BRC Inc. Redeemable Warrants, Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRVS / Corvus Pharmaceuticals, Inc.
VINC / Vincerx Pharma, Inc.
NKTR / Nektar Therapeutics Call
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
ALBO / Albireo Pharma Inc
CCXI / ChemoCentryx Inc
IMGN / ImmunoGen, Inc.
TNGX / Tango Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
LJPC / La Jolla Pharmaceutical Co.
NKTX / Nkarta, Inc.
VNDA / Vanda Pharmaceuticals Inc.
ITCI / Intra-Cellular Therapies, Inc.
BCAB / BioAtla, Inc.
RLMD / Relmada Therapeutics, Inc.
BLUE / bluebird bio, Inc.
HRTX / Heron Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
RVPH / Reviva Pharmaceuticals Holdings, Inc.
ANAB / AnaptysBio, Inc.
CHRS / Coherus Oncology, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
TCRX / TScan Therapeutics, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
TARS / Tarsus Pharmaceuticals, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
EQ / Equillium, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
NKTR / Nektar Therapeutics Put
BIO / Bio-Rad Laboratories, Inc.
ALLK / Allakos Inc.
ALT / Altimmune, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
ITOS / iTeos Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
ATYR / aTyr Pharma, Inc.
ANIP / ANI Pharmaceuticals, Inc.